Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04991831 · ClinicalTrials.gov registry record
A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease
A clinical trial of Tremor Associated With Tremor Dominant Parkinson's Disease, sponsored by InSightec.
- Recruiting
- Registry status
- 50
- Enrollment target
- 8
- Study locations
NCT04991831: Recruiting study of Tremor Associated With Tremor Dominant Parkinson's Disease, sponsored by InSightec.
NCT04991831 is a study of Tremor Associated With Tremor Dominant Parkinson's Disease that is actively recruiting participants, run by InSightec. The registered enrollment target is 50 participants. The trial reports 8 study locations across 7 states. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04991831, a study of Tremor Associated With Tremor Dominant Parkinson's Disease, is actively recruiting participants, sponsored by InSightec.
- RECRUITING
- Registry status
- 50 participants
- Enrollment target
- 8
- Study locations
Study Summary
The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.
Primary Outcome
This registry will collect the long-term safety data after performing thalamotomy for TDPD using the Exablate Neuro system.
Conditions Studied
Interventions
- DEVICE Unilateral thalamotomy
Study Locations (8)
Ohio
- Cleveland Clinic Foundation - Cleveland
- Miami Valley Hospital - Fairborn
Florida
- Miami Neuroscience Institute Baptist Health - Miami
Illinois
- Rush University - Chicago
Massachusetts
- Brigham and Women's Hospital - Boston
New York
- Weill Cornell Medicine - New York
North Carolina
- Novant Health Brain & Spine Surgery - Huntsville
Scotland
- University of Dundee - Dundee
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 50 participants |
| Start Date | 2022-04-28 |
| Est. Completion | 2027-12 |
What NCT04991831 shows while recruiting
NCT04991831 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 50 participants, a relatively small participant target.
The record links to 1 condition, with Tremor Associated With Tremor Dominant Parkinson's Disease appearing as the primary indexed condition, and to 1 intervention - of which Unilateral thalamotomy is the first listed.
NCT04991831 lists 8 locations in 7 states (Ohio, Florida, Illinois).
Frequently Asked Questions
What is clinical trial NCT04991831 about?
NCT04991831 is a clinical study titled "A Post-Approval Registry for Exablate 4000 Type 1.0 and Type 1.1 for Unilateral Thalamotomy for the Treatment of Medication-Refractory Tremor Dominant Idiopathic Parkinson's Disease". The objectives of this study are to collect the long-term safety and effectiveness data of performing thalamotomy for tremor dominant Parkinson's Disease (TDPD) using the Exablate Neuro system.
What is the current status of trial NCT04991831?
This trial is currently recruiting. The enrollment target is 50 participants. The study started on 2022-04-28. Estimated completion is 2027-12.
What conditions does trial NCT04991831 study?
This clinical trial studies the following conditions: Tremor Associated With Tremor Dominant Parkinson's Disease.
What interventions are being tested in trial NCT04991831?
The interventions under investigation include: Unilateral thalamotomy (DEVICE).
Who is sponsoring clinical trial NCT04991831?
This trial is sponsored by InSightec, which has 38 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04991831 being conducted?
This trial has 8 study locations across Florida, Illinois, Massachusetts, New York, North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT00200889 · 50 participants · Early Phase 1
Mapping Auricular Vagus Nerve Circuitry
- NCT00409435 · 50 participants · Phase 2
A Study of Pyridostigmine in Postural Tachycardia Syndrome
- NCT01202305 · 50 participants
The Use of Lymph Node Biopsies to Support HIV Pathogenesis Studies
- NCT01225913 · 50 participants · Phase 4
Mechanism(s) of Airflow Limitation During Exacerbation of Asthma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI